Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide for Abdominal Girth in IBS-C
NCT02837783Phase 4Terminated
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Dec 2016
- Primary completion
- Oct 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of linaclotide in irritable bowel syndrome (IBS), sponsored by Ironwood Pharmaceuticals. Started Dec 2016; status: terminated.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02837783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02837783.